A Method of Effectively Improved α-Mangostin Bioavailability.

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Drug Delivery Systems

Background:

• Alpha-mangostin (α-Mangostin), a xanthone from Garcinia mangostana, shows anti-inflammatory and antitumor potential.
• Poor oral absorption limits the therapeutic efficacy of α-Mangostin.
• Developing effective delivery systems is crucial for harnessing α-Mangostin's benefits.

Purpose of the Study:

• To enhance the oral bioavailability of α-Mangostin.
• To evaluate the pharmacokinetics and tissue distribution of a novel α-Mangostin soft capsule formulation in rats.

Main Methods:

• Preparation of a soft capsule using vegetable oil as a dispersion matrix for α-Mangostin.
• Development and validation of an High-Performance Liquid Chromatography (HPLC) assay for quantifying α-Mangostin in biological samples.
• Conducting pharmacokinetic and tissue distribution studies in rats following intravenous (i.v.) and oral administration.

Main Results:

• The HPLC method was successfully validated for accurate quantification of α-Mangostin.
• Pharmacokinetic studies demonstrated significantly improved absolute bioavailability of α-Mangostin with the soft capsule formulation.
• Observed absolute bioavailabilities were 61.1% (low dose), 51.5% (medium dose), and 42.5% (high dose).

Conclusions:

• The developed soft capsule formulation effectively enhances the oral bioavailability of α-Mangostin.
• This formulation represents a promising strategy for improving the therapeutic potential of α-Mangostin.
• Further research can explore this delivery system for other poorly absorbed natural compounds.